Business · 24/09/2004

National Institutes of Health to Grant Partially-Exclusive Licenses for Human-Bovine Rotavirus Vaccine

The National Institutes of Health is issuing a notice of intent to grant partially-exclusive licenses for the use of a multivalent human-bovine rotavirus vaccine in India, China, and Brazil, with specific exclusivity agreements in place with Biological E LTD and Bharat Biotech International LTD in India, and Fundacao Instituto Butantan in Brazil.